Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Mario Rodríguez et al.|European Journal Of Haematology|2020Cited by 96
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple MyelomaAlba Rodríguez-García, María Linares, Pablo Justo et al.|Clinical Cancer Research|2023Cited by 59
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myelomaJoaquín Martínez‐López, Beatriz Sánchez-Vega, Santiago Barrio et al.|Leukemia|2017Cited by 51
Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global networkA. Sanz, Joaquín Martínez‐López, Rosa Ayala et al.|Blood Cancer Journal|2022Cited by 24
Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapyAlba Rodríguez-García, María José Pedraja Linares, Raquel Ancos-Pintado et al.|Microbiome|2025Cited by 15